Jie Guo

Dr. Jie Guo

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2024 in Oncogene
Verified
Journal Article
Closed access
PDF file
SZShuangshuang Zhang
Shuangshuang Zhang
YGYeqi Gu
Yeqi Gu
JGJiaxin Ge
Jiaxin Ge
YXYaoyao Xie
Yaoyao Xie
XYXiuchong Yu
Xiuchong Yu
JGJunming Guo
Junming Guo

11 February 2022 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
YTYe Tian
Ye Tian
ZXZhigao Xue
Zhigao Xue
QZQingqing Zhao
Qingqing Zhao
JGJie Guo
Jie Guo
KTKai Tao
Kai Tao
LHLei Han
Lei Han
Hierarchical core–shell hollow Co3S4@NiCo2O4 nanosheet arrays have been constructed through a MOF-engaged strategy, and they exhibit significantly boosted electrochemical performance.

17 December 2021 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Closed access
JGJie Guo
Jie Guo
JGJiaxin Ge
Jiaxin Ge
YGYanan Guo
Yanan Guo

28 January 2025 in Journal of Alloys and Compounds
Verified
Journal Article
Closed access
JLJingxiang Liu
Jingxiang Liu
SLSheng Lv
Sheng Lv
HHHaoquan Hao
Haoquan Hao
HZHairui Zhao
Hairui Zhao
Wenhao WangWenhao Wang
Wenhao Wang
ZWZhijiang Wang
Zhijiang Wang

17 November 2022 in Inorganic Chemistry
Verified
Journal Article
Closed access
XMXuechun Ma
Xuechun Ma
DXDongdong Xu
Dongdong Xu
JGJie Guo
Jie Guo
KTKai Tao
Kai Tao
YHYaoping Hu
Yaoping Hu
LHLei Han
Lei Han

15 May 2025 in Cell Death Discovery
Verified
Journal Article
Open access
JGJiaxin Ge
Jiaxin Ge
JDJi Dai
Ji Dai
HJHaoqiang Ji
Haoqiang Ji
JGJie Guo
Jie Guo
XSXiaoban Shen
Xiaoban Shen
SZShuangshuang Zhang
Shuangshuang Zhang
Gastric cancer (GC) is one of the most common malignancies with a poor prognosis. The development of novel biomarkers is of utmost importance to screen patients with GC. Molecular mechanism study of GC may provide a research basis for the development of targeted drugs. We identified tRF-29-79MP9P9NH525 (tRF-29) as a GC-associated tRNA-derived fragment (tRF). The specific hair-pin structure reverse primer and amplification primers were first designed and then applied for tRF-29 quantification. Receiver operator characteristic curve, Kaplan–Meier survival curve, and multivariate Cox analysis were applied to analyze the diagnostic and prognostic values of tRF-29 in GC. Ethynyl-2′-deoxyuridine, cell cloning, Transwell assay, and flow cytometry were used to detect the effects of tRF-29 on proliferation, migration, and cell cycle distribution of GC cells. Xenograft tumor formation in NOD-SCID mice was applied in determining tRF-29′s effects on tumor growth. Fluorescence in situ hybridization, dual luciferase reporter assay, Western blot, immunohistochemistry, and RNA-binding protein immunoprecipitation were conducted to explore the molecular mechanism underlying tRF-29 regulating GC development. It was found that tissue tRF-29 showed effective diagnostic efficiency in GC and could discriminate different gastric mucosa. Besides, plasma tRF-29 improved GC diagnostic values of common tumor markers and had prognostic values in GC. tRF-29 was found to suppress proliferation and cell cycle progression. tRF-29 inhibited the growth of xenograft tumors. Mechanically, tRF-29 exerted Kinesin family member 14 (KIF14) mRNA destabilization by combining with argonaute 2 (Ago2) and regulated AKT/P27 pathway. In conclusion, tRF-29 inhibited GC progression by combining with Ago2 and regulated AKT/P27 pathway by silencing KIF14 expression.